Latest From Biotech Now

New Report Shows Value of Quality Measures for Adult Vaccines

Adult vaccination

Every year, more than 40,000 American adults are hospitalized or die due to vaccine-preventable diseases. Treating vaccine-preventable diseases among adults also costs the U.S. tens of billions of dollar every year. Improving rates of adult vaccination is a national imperative as the U.S. population ages at an unprecedented rate of 78 million Baby Boomers becoming senior citizens. In a new white paper, The Value and Imperative of Quality Measures for Adult Vaccines, renowned vaccine experts — Read More >

Health  |  Leave a comment  |  Email This Post
Tags: ,

Take Action: Sarcoma Awareness Month

sarcomaawarenesswithSA

The pages on the calendar have quickly turned and July is again upon us.  For most, July means freedom from school, a summer vacation, or celebrating our nation’s independence.  But those of us in the sarcoma community know that this month means something else as well.  As we know, July is Sarcoma Awareness Month. Why do we have a Sarcoma Awareness Month?  Simply, sarcoma is still considered to be the “forgotten cancer.”  Our efforts to encourage Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Correcting the Record On Politico’s Misinformed Article

new-bio-logo

Politico recently explored the relationship between the biopharmaceutical industry and the Affordable Care Act (ACA). The article laments the supposed high cost of drugs and implicitly endorses policies that would not only do little for patients in need of medications, but also stifle innovation through research and development. The implication that the “structural reforms” the story talks about would fundamentally change drug costs in this country is myopic and misinformed. Those so-called “reforms” like top-down, Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , ,

A Rehash Of Tired, Old Ideas From President Obama

new-bio-logo

Many of the biopharmaceutical policy proposals laid out by President Obama in his JAMA article (United States Health Care Reform: Progress to Date and Next Steps) are simply a rehash of tired, old ideas that have been rejected by bipartisan majorities in the Congress for years. The plans he lays out would do little or nothing to improve our shared goal of increasing patients’ access to medicines and could impede the development of new medical Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Applauds Federal Approach to GMO Disclosure

corn-&-tractor2

BIO applauds today’s vote in the U.S. House of Representatives to approve a federal, uniform approach to GMO disclosure.  The House voted 306-117 shortly after noon today, sending the long-debated bill to President Obama’s desk for signature. “The Congress’ strong, bipartisan support for a national GMO labeling and disclosure solution is a win for consumers, farmers, businesses, and agricultural innovation,” said Jim Greenwood, BIO’s President and CEO. “We commend the many leaders in the U.S. Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,